{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:14Z","timestamp":1787020874749,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The antigen avoidance has been used in the diagnosis and treatment of hypersensitivity pneumonitis (HP); however, its usefulness in stable fibrotic HP is controversial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the usefulness of the antigen avoidance test in patients with fibrotic HP in stable phase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The antigen avoidance test was conducted during a 2-week hospitalization comparing clinical parameters at admission and before discharge. A retrospective review of patients who underwent surgical lung biopsy or transbronchial lung cryobiopsy, who were diagnosed with fibrotic HP by multi-disciplinary discussion, and whose disease progression was stable for more than two months before the antigen avoidance test was done.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Between 2016 and 2021, 40 patients met the criteria, and 17 (43%) patients had a positive antigen avoidance test. The patients with positive in the antigen avoidance test had significantly greater annual forced vital capacity (FVC) decline than those with negative before the test (\u2212\u20096.5% vs.\u2009\u2212\u20090.3%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.045). The patients with positive antigen avoidance test had less annual FVC decline than those with negative in the year following the test (0.8% vs.\u2009\u2212\u20095.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.048). The differences in annual improvement were found for serum Krebs von den Lungen-6 between the positive and negative patients in the year following the test (\u2212\u200927% vs.\u2009\u2212\u20095%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.049). In multivariate Cox hazard regression analysis, a negative result of the antigen avoidance test was a risk factor for death or acute exacerbation of fibrotic HP (HR\u2009=\u20090.26 [95% CI: 0.07\u20130.90],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.034).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In fibrotic HP patients in stable phase, the antigen avoidance test under a 2-week hospitalization was valuable in predicting prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13223-022-00748-1","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T03:03:11Z","timestamp":1670554991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of antigen avoidance test for fibrotic hypersensitivity pneumonitis in stable phase"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8691-7773","authenticated-orcid":false,"given":"Ryo","family":"Okuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamiko","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae","family":"Iwasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Kaburaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"issue":"1","key":"748_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0091-6749(84)90077-0","volume":"74","author":"JN Fink","year":"1984","unstructured":"Fink JN. Hypersensitivity pneumonitis. J Allergy Clin Immunol. 1984;74(1):1\u201310.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"748_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1136\/thx.23.5.451","volume":"23","author":"EJ Hapke","year":"1968","unstructured":"Hapke EJ, Seal RM, Thomas GO, Hayes M, Meek JC. Farmer\u2019s lung. A clinical, radiographic, functional, and serological correlation of acute and chronic stages. Thorax. 1968;23(5):451\u201368.","journal-title":"Thorax"},{"issue":"5 Pt 2","key":"748_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/0091-6749(89)90349-7","volume":"84","author":"HB Richerson","year":"1989","unstructured":"Richerson HB, Bernstein IL, Fink JN, et al. Guidelines for the clinical evaluation of hypersensitivity pneumonitis. Report of the Subcommittee on Hypersensitivity Pneumonitis. J Allergy Clin Immunol. 1989;84(5 Pt 2):839\u201344.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"748_CR4","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","volume":"202","author":"G Raghu","year":"2020","unstructured":"Raghu G, Remy-Jardin M, Ryerson CJ, et al. Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;202(3):e36\u201369.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"748_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S2213-2600(13)70191-7","volume":"1","author":"F Morell","year":"2013","unstructured":"Morell F, Villar A, Montero MA, et al. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. Lancet Respir Med. 2013;1(9):685\u201394.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"748_CR6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.chest.2015.12.030","volume":"149","author":"S Chiba","year":"2016","unstructured":"Chiba S, Tsuchiya K, Akashi T, et al. Chronic hypersensitivity pneumonitis with a usual interstitial pneumonia-like pattern: correlation between histopathologic and clinical findings. Chest. 2016;149(6):1473\u201381.","journal-title":"Chest"},{"issue":"3","key":"748_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1309\/AJCPNWX4SLZRP9SW","volume":"131","author":"T Akashi","year":"2009","unstructured":"Akashi T, Takemura T, Ando N, et al. Histopathologic analysis of sixteen autopsy cases of chronic hypersensitivity pneumonitis and comparison with idiopathic pulmonary fibrosis\/usual interstitial pneumonia. Am J Clin Pathol. 2009;131(3):405\u201315.","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"748_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.resinv.2015.04.003","volume":"53","author":"T Tsutsui","year":"2015","unstructured":"Tsutsui T, Miyazaki Y, Okamoto T, et al. Antigen avoidance tests for diagnosis of chronic hypersensitivity pneumonitis. Respir Investig. 2015;53(5):217\u201324.","journal-title":"Respir Investig"},{"key":"748_CR9","first-page":"7","volume":"89","author":"ER Fernandez Perez","year":"2021","unstructured":"Fernandez Perez ER, Travis WD, Lynch DA, et al. Executive Summary Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Panel Report. Chest. 2021;89:7.","journal-title":"Chest"},{"issue":"4","key":"748_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/thoraxjnl-2017-210035","volume":"73","author":"A Gimenez","year":"2018","unstructured":"Gimenez A, Storrer K, Kuranishi L, Soares MR, Ferreira RG, Pereira CAC. Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis. Thorax. 2018;73(4):391\u20132.","journal-title":"Thorax"},{"issue":"1","key":"748_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12931-021-01748-2","volume":"22","author":"J Kang","year":"2021","unstructured":"Kang J, Kim YJ, Choe J, Chae EJ, Song JW. Acute exacerbation of fibrotic hypersensitivity pneumonitis: incidence and outcomes. Respir Res. 2021;22(1):152.","journal-title":"Respir Res"},{"issue":"3","key":"748_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","volume":"194","author":"HR Collard","year":"2016","unstructured":"Collard HR, Ryerson CJ, Corte TJ, et al. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. Am J Respir Crit Care Med. 2016;194(3):265\u201375.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"748_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1378\/chest.96.1.68","volume":"96","author":"N Kohno","year":"1989","unstructured":"Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest. 1989;96(1):68\u201373.","journal-title":"Chest"},{"issue":"12","key":"748_CR14","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.rmed.2015.10.005","volume":"109","author":"T Okamoto","year":"2015","unstructured":"Okamoto T, Fujii M, Furusawa H, Tsuchiya K, Miyazaki Y, Inase N. The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis. Respir Med. 2015;109(12):1576\u201381.","journal-title":"Respir Med"},{"issue":"3","key":"748_CR15","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.chest.2017.02.011","volume":"152","author":"P Wang","year":"2017","unstructured":"Wang P, Jones KD, Urisman A, et al. Pathologic findings and prognosis in a large prospective cohort of chronic hypersensitivity pneumonitis. Chest. 2017;152(3):502\u20139.","journal-title":"Chest"},{"issue":"2","key":"748_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1440-1843.2012.02272.x","volume":"18","author":"T Harada","year":"2013","unstructured":"Harada T, Watanabe K, Nabeshima K, Hamasaki M, Iwasaki H. Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non-specific interstitial pneumonia. Respirology. 2013;18(2):278\u201383.","journal-title":"Respirology"},{"issue":"12","key":"748_CR17","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1097\/PAS.0b013e3181bb2538","volume":"33","author":"A Churg","year":"2009","unstructured":"Churg A, Sin DD, Everett D, Brown K, Cool C. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2009;33(12):1765\u201370.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"748_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/MD.0b013e31816d1dda","volume":"87","author":"F Morell","year":"2008","unstructured":"Morell F, Roger A, Reyes L, Cruz MJ, Murio C, Munoz X. Bird fancier\u2019s lung: a series of 86 patients. Medicine (Baltimore). 2008;87(2):110\u201330.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"748_CR19","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1378\/chest.118.5.1382","volume":"118","author":"Y Ohtani","year":"2000","unstructured":"Ohtani Y, Kojima K, Sumi Y, et al. Inhalation provocation tests in chronic bird fancier\u2019s lung. Chest. 2000;118(5):1382\u20139.","journal-title":"Chest"},{"issue":"12","key":"748_CR20","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1111\/cea.13752","volume":"50","author":"R Okuda","year":"2020","unstructured":"Okuda R, Takemura T, Mikami Y, et al. Inhalation challenge test using pigeon eggs for chronic hypersensitivity pneumonitis. Clin Exp Allergy. 2020;50(12):1381\u201390.","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"748_CR21","first-page":"407","volume":"130","author":"K Shimazu","year":"1984","unstructured":"Shimazu K, Ando M, Sakata T, Yoshida K, Araki S. Hypersensitivity pneumonitis induced by Trichosporon cutaneum. Am Rev Respir Dis. 1984;130(3):407\u201311.","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"748_CR22","first-page":"51","volume":"22","author":"R Janssen","year":"2005","unstructured":"Janssen R, Grutters JC, Sato H, et al. Analysis of KL-6 and SP-D as disease markers in bird fancier\u2019s lung. Sarcoidosis Vasc Diffuse Lung Dis. 2005;22(1):51\u20137.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-022-00748-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-022-00748-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-022-00748-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T03:09:12Z","timestamp":1670555352000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-022-00748-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["748"],"URL":"https:\/\/doi.org\/10.1186\/s13223-022-00748-1","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"assertion":[{"value":"21 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research Ethics Committee, Kanagawa Cardiovascular and Respiratory Center, Kanagawa Prefectural Hospital Organization approved the study with a waiver of consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript contains no individual details requiring consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}